TherapeuticsMD, Inc. (TXMD or the Company) announced key leadership changes, including the appointment of Hugh O?Dowd, the Company?s current President, as member of the board of directors. Mr. O?Dowd will succeed Robert G. Finizio, the Company?s Co-founder and current Chief Executive Officer, effective on or before December 31, 2021. Mr. Finizio will continue with the Company and has been appointed Vice Chair of the Board of Directors.